Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
DMAA

Drugs Made In America Acquisition Corp. (DMAA)

NASDAQ
$10.90
-$0.00
(-0.01%)
Previous Close: ⁦$10.90⁩
Market Closed

Last updated: ⁦2026-11-19 07:49:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Drugs Made In America Acquisition Corp. (DMAA) operates in the BLANK CHECKS sector and is listed on NASDAQ. The stock is currently priced at $10.90, with a market capitalization of $264.62M and a P/E ratio of 32.39. Over the past 52 weeks, its price has ranged from $10.32 to $10.91. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$264.62M

$10.90

$10.90

$10.90

$10.90

241.00

23.04K

32.39

$10.91

$10.32

--

2026-06-30

Drugs Made In America Acquisition Corp. (DMAA) Latest Closing Stock Price

Drugs Made In America Acquisition Corp. (DMAA) last closed at $10.90 as of 2026-11-18 20:55:00, down 0.01% ($0.00) from the previous close of $10.90.

During the latest regular trading session, DMAA traded between $10.90 and $10.90, with a volume of 241.00 shares. The closing price was near the lower end and near the upper end of its 52-week range.

Drugs Made In America Acquisition Corp. (DMAA) 7-Day Stock Price Change

Over the past seven days, Drugs Made In America Acquisition Corp. (DMAA) moved from $10.89 to $10.90, representing a gain of 0.09% ($0.01).

The stock traded between $10.89 and $10.91 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 15.40 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

DMAA 52-Week Price Position

Position in Range: 98.3%

52W Low$10.32
52W High$10.91

DMAA is currently trading at $10.90, placing it 98.3% of the way from its 52-week low of $10.32 to its 52-week high of $10.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Drugs Made In America Acquisition Corp. (DMAA)?

Drugs Made In America Acquisition Corp is a blank check company.

Drugs Made In America Acquisition Corp. Information

Industry
BLANK CHECKS
Exchange
NASDAQ

Ways to Trade DMAA at MEXC

DMAA MEXC RealStocks

Own real DMAA shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Drugs Made In America Acquisition Corp. (DMAA) Stock on MEXC

Eligible investors can buy real shares of Drugs Made In America Acquisition Corp. (DMAA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for DMAA and Place Your Order
Step 3: Search for DMAA and Place Your Order
Open the RealStocks trading page and search for DMAA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Drugs Made In America Acquisition Corp. (DMAA) stock price today?
Drugs Made In America Acquisition Corp. (DMAA) is currently trading at $10.90, down 0.01% ($0.00) from the previous close of $10.90. Intraday prices update in real time during regular trading hours.
2.Is DMAA stock going up or down today?
As of 2026-11-18 20:55:00, DMAA is trading at $10.90, down 0.01% ($0.00) from its previous close of $10.90. The stock has traded between $10.90 and $10.90 during today’s regular session. Past price movements do not guarantee future results.
3.What is DMAA pre-market price?
As of 2026-11-18 20:55:00, DMAA is trading at $10.90 in pre-market trading, unchanged from the previous close of $10.90. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is DMAA after-hours price?
As of 2026-11-18 20:55:00, DMAA is trading at $10.90 in after-hours trading, unchanged from the regular-session close of $10.90. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is DMAA stock trading now?
DMAA trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does DMAA sit relative to its 52-week high and low?
Over the past 52 weeks, DMAA has traded between a low of $10.32 and a high of $10.91. At $10.90, the stock is positioned 98.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Drugs Made In America Acquisition Corp. in?
Drugs Made In America Acquisition Corp. (DMAA) operates in the BLANK CHECKS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Drugs Made In America Acquisition Corp.'s market capitalization and where is it listed?
Drugs Made In America Acquisition Corp. is listed on the NASDAQ exchange with a market capitalization of $264.62M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is DMAA valued in terms of P/E ratio and EPS?
DMAA trades at a P/E ratio of 32.39, based on trailing-twelve-month EPS of $0.34. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Drugs Made In America Acquisition Corp. pay a dividend?
Drugs Made In America Acquisition Corp. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DMAA, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

DMAA Stock Calculator

Estimate the value between DMAA shares and USD.

DMAA Shares to USD

DMAA Shares
DMAA
DMAA
USD
USD
USD

1.00 DMAA shares = 10.9 USD

Calculations are estimates based on the latest available price and are for reference only.